1. Home
  2. AZI vs CTMX Comparison

AZI vs CTMX Comparison

Compare AZI & CTMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Autozi Internet Technology (Global) Ltd. Class A Ordinary Shares

AZI

Autozi Internet Technology (Global) Ltd. Class A Ordinary Shares

HOLD

Current Price

$1.68

Market Cap

1.2M

Sector

N/A

ML Signal

HOLD

Logo CytomX Therapeutics Inc.

CTMX

CytomX Therapeutics Inc.

HOLD

Current Price

$4.18

Market Cap

596.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AZI
CTMX
Founded
2010
2008
Country
China
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2M
596.2M
IPO Year
2024
2015

Fundamental Metrics

Financial Performance
Metric
AZI
CTMX
Price
$1.68
$4.18
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$6.50
AVG Volume (30 Days)
795.2K
2.1M
Earning Date
01-28-2026
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
50.22
EPS
N/A
0.24
Revenue
$156,466,000.00
$113,631,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$17.49
Revenue Growth
32.90
N/A
52 Week Low
$1.62
$0.40
52 Week High
$69.00
$4.62

Technical Indicators

Market Signals
Indicator
AZI
CTMX
Relative Strength Index (RSI) 96.66 57.36
Support Level $0.03 $3.78
Resistance Level $0.06 $4.20
Average True Range (ATR) 0.05 0.24
MACD 0.11 -0.02
Stochastic Oscillator 73.30 73.88

Price Performance

Historical Comparison
AZI
CTMX

About AZI Autozi Internet Technology (Global) Ltd. Class A Ordinary Shares

Autozi Internet Technology (Global) Ltd provides high-quality, affordable, and professional one-stop automotive products and services through online and offline channels in China. Leveraging its online supply chain cloud platform, SaaS platforms, and the network of MBS stores, It has established an ecosystem of lifecycle automotive services by connecting automotive manufacturers, auto parts manufacturers, and insurance companies with MBS stores and various automotive owners. Its business segments include new car sales, auto parts and auto accessories sales, and automotive insurance-related services. The majority of revenue is from the new car sales segment, and auto parts & auto accessories sales.

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

Share on Social Networks: